Pronóstico del mercado de bioproducción de Asia Pacífico hasta 2030 – Análisis regional – por producto (productos biológicos y biosimilares, vacunas, terapias celulares y genéticas, terapias con ácidos nucleicos y otros), aplicación (artritis reumatoide, trastornos hematológicos, cáncer, diabetes, enfermedades cardiovasculares y otros) ), equipos (equipos ascendentes, equipos descendentes, biorreactores y consumibles y accesorios) y usuarios finales (compañías biofarmacéuticas, organizaciones de fabricación por contrato y otros)
La expiración de la patente de productos biológicos de gran éxito impulsa el mercado de bioproducción de Asia Pacífico
Los productos biológicos representan nuevas terapias prometedoras para enfermedades previamente incurables y están adquiriendo gran importancia en el mercado farmacéutico. Se espera que las patentes sobre productos biológicos originales expiren en los próximos años.
En la siguiente tabla se muestran las fechas estimadas de vencimiento de patentes y exclusividad de los productos biológicos más vendidos.
Fechas de caducidad de los productos biológicos
Fechas de caducidad de los productos biológicos
Avastin
enero de 2022
Cyramza
mayo de 2023
Adcetris
agosto de 2023
Abthrax < br> Octubre de 2024
Gazyva/Gazyvaro
Noviembre de 2024
Darzalex
Mayo de 2026
Ocrevus
Abril de 2027
Emgality
Septiembre de 2028
Hemlibra
Febrero 2028
Llumetri
marzo 2028
Imfinzi
septiembre 2028
Mylotarg
abril 2028
Imfinzi
septiembre 2028
Mylotarg
abril 2028
Sylvant
Julio de 2034
La expiración de la patente y otros derechos de propiedad intelectual de los productos biológicos originales crearán la necesidad de introducir nuevos biosimilares en el futuro. Como resultado, la competencia entre los actores del mercado aumentará en la industria en los próximos años. Por lo tanto, se espera que la expiración de las patentes de productos biológicos de gran éxito cree oportunidades lucrativas para el mercado de bioproducción durante el período previsto.
Descripción general del mercado de bioproducción de Asia Pacífico
El mercado de bioproducción de Asia Pacífico está segmentado en China, Japón, India, Corea del Sur, Australia, Corea del Sur y el resto de Asia Pacífico. Se prevé que el crecimiento del mercado en Asia Pacífico crecerá a un ritmo más rápido debido a factores como la creciente necesidad de soluciones de tratamiento superiores, un mayor enfoque en actividades de investigación y desarrollo y escenarios regulatorios favorables. Además, se estima que el aumento de las inversiones y el desarrollo de infraestructura sanitaria para impulsar las actividades de investigación impulsarán el mercado de bioproducción de Asia Pacífico durante 2022-2030.
En China, la demanda de atención sanitaria está aumentando rápidamente. Factores como la creciente población geriátrica, la creciente incidencia de enfermedades crónicas y el aumento de las iniciativas gubernamentales en el sector de la salud están impulsando el mercado de la terapia celular en China. Las mejoras en los planes de seguro médico básico y privado también han acelerado el crecimiento del sector médico en el país. Los crecientes niveles de ingresos han llevado a la demanda de servicios de salud más sofisticados. El aumento de la población geriátrica ha provocado un aumento de la comunidad médica especializada en el país. En China, es probable que la creciente prevalencia del cáncer aumente la adopción de la terapia celular. Según el Registro Nacional Central de Cáncer de China, se registraron 4,3 millones de nuevos casos de cáncer en China.
Ingresos del mercado de bioproducción de Asia Pacífico y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de bioproducción de Asia Pacífico
El mercado de bioproducción de Asia Pacífico se clasifica en producto, aplicación, equipo y usuario final y país.
Según el producto, el mercado de bioproducción de Asia Pacífico se segmenta en productos biológicos y biosimilares, vacunas, terapias celulares y genéticas, terapias con ácidos nucleicos y otros. El segmento de productos biológicos y biosimilares tuvo la mayor participación de mercado de bioproducción de Asia Pacífico en 2022.
En términos de aplicación, el mercado de bioproducción de Asia Pacífico está segmentado en artritis reumatoide, trastornos hematológicos, cáncer, diabetes, enfermedades cardiovasculares y otros. El segmento del cáncer tuvo la mayor cuota de mercado de bioproducción de Asia Pacífico en 2022.
Por equipos, el mercado de bioproducción de Asia Pacífico se divide en equipos ascendentes, equipos descendentes, biorreactores y consumibles y accesorios. El segmento de consumibles y accesorios tuvo la mayor participación de mercado de bioproducción de Asia Pacífico en 2022.
En términos de usuario final, el mercado de bioproducción de Asia Pacífico se clasifica en empresas biofarmacéuticas, organizaciones de fabricación por contrato y otras. El segmento de empresas biofarmacéuticas tuvo la mayor cuota de mercado de bioproducción de Asia Pacífico en 2022.
Por país, el mercado de bioproducción de Asia Pacífico está segmentado en Australia, China, India, Japón, Corea del Sur y el resto de Asia Pacífico. China dominó la cuota de mercado de bioproducción de Asia Pacífico en 2022.
Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, y Bio-Rad Laboratories Inc. son algunas de las empresas líderes que operan en el mercado de bioproducción de Asia Pacífico.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Asia Pacific Market Analysis
5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Asia Pacific: Bioproduction Market
10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. bbi-biotech GmbH
3. Danaher Corp
4. Sartorius AG
5. FUJIFILM Irvine Scientific Inc
6. Thermo Fisher Scientific Inc
7. Merck KGaA
8. F. Hoffmann-La Roche Ltd
9. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.